IDH1 and central nervous system cancer: It has been shown in in silico studies that IDH1-mutant gliomas have significantly higher lactate dehydrogenase B expression comparing to wild-type tumours; and higher lactate oxidation was hypothesised in IDH1 mutation bearing cells [20].